Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant

被引：22
|
作者：
Del Corso, I. [1 ]
Puxeddu, I. [1 ]
Sardano, E. [1 ]
Geraci, S. [2 ]
Breggia, M. [2 ]
Rocchi, V. [1 ]
Migliorini, P. [1 ]
机构：
[1] Univ Pisa, Clin Immunol Unit, Dept Internal Med, I-56100 Pisa, Italy
[2] Grosseto Hosp, Emergency Dept, Grosseto, Italy
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2012年 / 108卷 / 06期
关键词：
D O I：
10.1016/j.anai.2012.03.013
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：460 / 461
页数：2
相关论文
共 50 条
  • [1] Treatment for hereditary angioedema with the bradykinin (B2) receptor antagonist Icatibant (JE 049)
    Rosenkranz, B
    Meng, G
    Knolle, J
    Bork, K
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 : 166 - 167
  • [2] Icatibant, a new bradykinin B2 receptor antagonist, for hereditary angioedema attacks
    Reshef, A.
    Liebovich, I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S102 - S102
  • [3] Treatment of idiopathic angio-edema with Icatibant, a bradykinin B2 receptor antagonist
    Bork, K.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 177 - 177
  • [4] Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist
    Pucar, Phillippa A.
    O'Sullivan, Michael
    Goudie, Adrian
    Marr, Timothy
    Brusch, Anna
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2015, 202 (11) : 596 - 597
  • [5] Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema
    Greve, Jens
    Hoffmann, Thomas K.
    Schuler, Patrick
    Lang, Stephan
    Chaker, Adam
    Bas, Murat
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2011, 50 (10) : 1294 - 1295
  • [6] Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant
    Krause, Karoline
    Metz, Martin
    Zuberbier, Torsten
    Maurer, Marcus
    Magerl, Markus
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (04): : 272 - 274
  • [7] Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant
    Schmidt, Peter W.
    Hirschl, Michael M.
    Trautinger, Franz
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (05) : 913 - 914
  • [8] At-Home Treatment of Patients with Acute Attacks of Hereditary Angioedema with the Bradykinin B2 Receptor-Antagonist Icatibant
    Farkas, H.
    Csuka, D.
    Zotter, Z.
    Varga, L.
    Boeroecz, Z.
    Temesszentandrasi, G.
    Karadi, I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB233 - AB233
  • [9] Successful long term treatment of 141 attacks in a patient with hereditary angioedema with the bradykinin B2 receptor antagonist icatibant
    Greve, J.
    Bas, M.
    Schuler, P.
    Schipper, J.
    Lang, S.
    Hoffmann, T.
    [J]. ALLERGY, 2009, 64 : 281 - 281
  • [10] Treatment of hereditary angioedema with normal C1-inhibitor with icatibant, a selective bradykinin B2 receptor antagonist
    Bork, K.
    [J]. ALLERGY, 2011, 66 : 427 - 428
12345